BACKGROUND: Idiopathic generalized epilepsy (IGE) is an epilepsy form without an underlying brain lesion or neurological indication or symptom. Recent investigations on the genetic origins of IGE and its subtypes report that certain mutations of various ion and non-ion channels genes in the central nervous system may be associated with IGE. PURPOSE: In this study we evaluated the relation between IGE and S430Y polymorphism in EFHC2 gene in a Turkish population. MATERIAL/ METHODS: The study enrolled 96 healthy volunteers (47 male, 49 female), served as controls, and 96 IGE patients (41 male, 55 female), IGE diagnosis was confirmed in the neurology department. DNA extractions were performed. The presence of S430Y polymorphism in the exon 9 of EFHC2 gene were analyzed by Real-Time PCR. The findings obtained from the control and patient groups were compared. RESULTS: In the patient group there was one heterozygous male with 685 T>C mutation. In the control group, there were two objects with 685 T>C mutation; one heterozygous male, one heterozygous female. 662 G>A mutation was determined in neither controls nor patients. CONCLUSION: In our series of 96 IGE patients and 96 healthy controls, there was no relation between S430Y polymorphism in EFHC2 gene and IGE presence.
BACKGROUND:Idiopathic generalized epilepsy (IGE) is an epilepsy form without an underlying brain lesion or neurological indication or symptom. Recent investigations on the genetic origins of IGE and its subtypes report that certain mutations of various ion and non-ion channels genes in the central nervous system may be associated with IGE. PURPOSE: In this study we evaluated the relation between IGE and S430Y polymorphism in EFHC2 gene in a Turkish population. MATERIAL/ METHODS: The study enrolled 96 healthy volunteers (47 male, 49 female), served as controls, and 96 IGEpatients (41 male, 55 female), IGE diagnosis was confirmed in the neurology department. DNA extractions were performed. The presence of S430Y polymorphism in the exon 9 of EFHC2 gene were analyzed by Real-Time PCR. The findings obtained from the control and patient groups were compared. RESULTS: In the patient group there was one heterozygous male with 685 T>C mutation. In the control group, there were two objects with 685 T>C mutation; one heterozygous male, one heterozygous female. 662 G>A mutation was determined in neither controls nor patients. CONCLUSION: In our series of 96 IGEpatients and 96 healthy controls, there was no relation between S430Y polymorphism in EFHC2 gene and IGE presence.
Authors: L H Eunson; R Rea; S M Zuberi; S Youroukos; C P Panayiotopoulos; R Liguori; P Avoni; R C McWilliam; J B Stephenson; M G Hanna; D M Kullmann; A Spauschus Journal: Ann Neurol Date: 2000-10 Impact factor: 10.422
Authors: Stéphanie Baulac; Isabelle Gourfinkel-An; Philippe Couarch; Christel Depienne; Anna Kaminska; Olivier Dulac; Michel Baulac; Eric LeGuern; Rima Nabbout Journal: Arch Neurol Date: 2008-07
Authors: Sarah E Heron; Ingrid E Scheffer; Samuel F Berkovic; Leanne M Dibbens; John C Mulley Journal: Neurotherapeutics Date: 2007-04 Impact factor: 7.620